Navigation Links
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:3/18/2008

. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's plans for and the potential market for Golimumab. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward- looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors th
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
2. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
3. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
4. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
5. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
6. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
7. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
10. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
11. Schering-Plough Completes Acquisition of Organon BioSciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...hed the Sixth Milestone in its Ofatumumab ...N, Denmark, October 10 /- G...d the sixth milestone for,ofatumumab (HuMax-CD20(R...SmithKline (GSK). A milestone payment of approxima...) was triggered by the first patient,receiving tre...
(Date:10/10/2008)...Oct. 10 /Xinhua-- Beike,Biotechnology...bal leader in,stem cell research and treatment thr...as signed eight separate mutual cooperation agreem...anding stem cell research organizations.,As part o...em Cell Expert,Advisory Committee" and a separate ...
(Date:10/10/2008)...RNewswire/ -- Twenty of Britain,s most,innovative ...bit their,ideas at the fifth annual SETsquared Par...eld at One Great George Street, London, from 8am o...m of technology innovators,in electronics, informa...Six companies will give 10-minute presentations to...
(Date:10/10/2008)...Newswire/ -- Takeda Pharmaceutical Company,Limited...earch and,Development Center, Inc., a wholly owned...ation that the U.S. Food and Drug Administration (...e alogliptin New Drug Application,(NDA) by the Pre...r 27,2008., "In our most recent discussion with ...
Breaking Biology Technology:Genmab Reaches Milestone in Ofatumumab Collaboration 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2
...sultant Tom Koulopoulos said at the Fusion2006 CE...identify information technology work they do that ... outside of the organization. As you might expect,...house raises a lot of questions, so WTN followed u...nce in IT and outsourcing. , ,This is part one of ...
Madison, Wis. Berbee Information Networks Corporation said it has been named Cisco Systems, U.S. IP communications partner of the year for 2005. , ,The award recognizes revenue growth and custom
...ht say the legacy of the 2005-2006 session of the ...y or Senate floor, but in court, where a few forme...e resources for campaigns. Others might say this L...y diet of social issues, from carrying concealed w...back the death penalty. , ,There,s a third way to...
..., Wis. The latest in a growing body of sharehold...g software developer dearly. , ,Alleging that memb...ties law, shareholders of Merge Technologies, Inc... management software, have filed several lawsuits ...Merge,s $325 million stock purchase of Cedara Corp...
Other Biology Technology:IT outsourcing according to Tom Koulopoulos, part 1 2IT outsourcing according to Tom Koulopoulos, part 1 3Four ways lawmakers could help Wisconsins high-growth economy 2Four ways lawmakers could help Wisconsins high-growth economy 3Merge's merger is the crux of shareholder lawsuits 2
(Date:10/10/2008)...tigators from the Herman B Wells Center for Pediat...edicine are focusing on a family of blood proteins...ic effects of chemotherapy in children and adults....opment of targeted therapies for leukemia, multipl...researchers, led by Kristin T. Chun, Ph.D., assist...
(Date:10/10/2008)...the 1950s, Austrian and Swiss scientists conducted...taking photographs of the glaciers, mountains and ...ist Fritz Mller spent eight months in the region a...raphing the Himalayan glaciers. , Now, fifty yea... these scientists are of immense value in trying t...
(Date:10/10/2008)...may make us all go a little gooey, but it,s not tu...health researchers at The Australian National Univ... Mental Health Research (CMHR) at ANU suggests th...ffects their cognitive functions, there is no evid...en released as part of Mental Health Week, which r...
(Date:10/9/2008)... conventional wisdom, tropical plant and animal sp...h may be threatened by global warming, according t...t Robert K. Colwell and colleagues in this week,s ...h,s climate has warmed in recent decades, the geog...nd plant species in the US and Europe have moved n...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Pregnancy not turning minds to mush: Study 2Tropical rainforest and mountain species may be threatened by global warming 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 1Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 3Mayo Clinic Proceedings January Tip Sheet 1228 1Mayo Clinic Proceedings January Tip Sheet 1228 2Mayo Clinic Proceedings January Tip Sheet 1228 3Molecule May Trigger Psoriasis 9780 1Case researcher in RNA biology makes waves by challenging current thinking 1964 1Case researcher in RNA biology makes waves by challenging current thinking 1964 2
... increasing among the general population in Canada...First Nations, Inuit and Métis children. In a stud...blic Health, University of Alberta researchers fou...northern Quebec communities were overweight or obe... at the University of Alberta, and her colleagues ...
... oldest questions in human physiology, researchers...hy the body,s immune system - perpetually on guard...ttack tissues in the small intestine that harbor m...ruary issue of Nature Immunology, and which is cur...dvanced online publication, investigators led by S...
...ext Generation," Geordi La Forge is a blind charac...implants in his eyes. While the Star Trek characte...e 21st century may not have to wait that long for ...m, a University of Missouri-Columbia veterinary op...mplant to help blind animals "see." According to N...
...ity researchers have discovered men with an unusua... than men the same age who are cognitively normal....A), a neurological disease in which people have tr...eople lose the ability to express themselves and u...r,s disease in which a person,s memory becomes imp...
Other Biology News:Why doesn't the immune system attack the small intestine? 2MU researcher placing eye implants in cats to help humans see 2Vasectomy may put men at risk for type of dementia 2Vasectomy may put men at risk for type of dementia 3
Hybridization Buffer 3.6 ml
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215
Glutathione Agarose Beads 10 ml
Biology Products: